Literature DB >> 15725977

US valuation of the EQ-5D health states: development and testing of the D1 valuation model.

James W Shaw1, Jeffrey A Johnson, Stephen Joel Coons.   

Abstract

PURPOSE: The EQ-5D is a brief, multiattribute, preference-based health status measure. This article describes the development of a statistical model for generating US population-based EQ-5D preference weights.
METHODS: A multistage probability sample was selected from the US adult civilian noninstitutional population. Respondents valued 13 of 243 EQ-5D health states using the time trade-off (TTO) method. Data for 12 states were used in econometric modeling. The TTO valuations were linearly transformed to lie on the interval [-1, 1]. Methods were investigated to account for interaction effects caused by having problems in multiple EQ-5D dimensions. Several alternative model specifications (eg, pooled least squares, random effects) also were considered. A modified split-sample approach was used to evaluate the predictive accuracy of the models. All statistical analyses took into account the clustering and disproportionate selection probabilities inherent in our sampling design.
RESULTS: Our D1 model for the EQ-5D included ordinal terms to capture the effect of departures from perfect health as well as interaction effects. A random effects specification of the D1 model yielded a good fit for the observed TTO data, with an overall R of 0.38, a mean absolute error of 0.025, and 7 prediction errors exceeding 0.05 in absolute magnitude.
CONCLUSIONS: The D1 model best predicts the values for observed health states. The resulting preference weight estimates represent a significant enhancement of the EQ-5D's utility for health status assessment and economic analysis in the US.

Mesh:

Year:  2005        PMID: 15725977     DOI: 10.1097/00005650-200503000-00003

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  456 in total

1.  Long-term outcomes after severe shock.

Authors:  Cristina M Pratt; Eliotte L Hirshberg; Jason P Jones; Kathryn G Kuttler; Michael J Lanspa; Emily L Wilson; Ramona O Hopkins; Samuel M Brown
Journal:  Shock       Date:  2015-02       Impact factor: 3.454

2.  The effect of weight loss on changes in health-related quality of life among overweight and obese women with urinary incontinence.

Authors:  Angela Marinilli Pinto; Leslee L Subak; Sanae Nakagawa; Eric Vittinghoff; Rena R Wing; John W Kusek; William H Herman; Delia Smith West; Miriam Kuppermann
Journal:  Qual Life Res       Date:  2011-12-10       Impact factor: 4.147

3.  Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial.

Authors:  Kevin D Frick; Lea T Drye; John H Kempen; James P Dunn; Gary N Holland; Paul Latkany; Narsing A Rao; H Nida Sen; Elizabeth A Sugar; Jennifer E Thorne; Robert C Wang; Janet T Holbrook
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-09       Impact factor: 4.799

4.  Population-level response shift: novel implications for research.

Authors:  Darren Lau; Calypse Agborsangaya; Fatima Al Sayah; Xiuyun Wu; Arto Ohinmaa; Jeffrey A Johnson
Journal:  Qual Life Res       Date:  2011-11-18       Impact factor: 4.147

5.  Does the EQ-5D reflect lost earnings?

Authors:  Carl Tilling; Marieke Krol; Aki Tsuchiya; John Brazier; Job van Exel; Werner Brouwer
Journal:  Pharmacoeconomics       Date:  2012-01       Impact factor: 4.981

6.  Quality-adjusted life expectancy (QALE) loss due to smoking in the United States.

Authors:  Haomiao Jia; Matthew M Zack; William W Thompson; Shanta R Dube
Journal:  Qual Life Res       Date:  2012-02-18       Impact factor: 4.147

7.  The impact of co-morbidity burden on preference-based health-related quality of life in the United States.

Authors:  Patrick W Sullivan; Vahram H Ghushchyan; Elizabeth A Bayliss
Journal:  Pharmacoeconomics       Date:  2012-05       Impact factor: 4.981

8.  Protocolized Care for Early Septic Shock (ProCESS) statistical analysis plan.

Authors:  Francis Pike; Donald M Yealy; John A Kellum; David T Huang; Amber E Barnato; Tammy L Eaton; Derek C Angus; Lisa A Weissfeld
Journal:  Crit Care Resusc       Date:  2013-12       Impact factor: 2.159

9.  Surgical treatment of spinal stenosis with and without degenerative spondylolisthesis: cost-effectiveness after 2 years.

Authors:  Anna N A Tosteson; Jon D Lurie; Tor D Tosteson; Jonathan S Skinner; Harry Herkowitz; Todd Albert; Scott D Boden; Keith Bridwell; Michael Longley; Gunnar B Andersson; Emily A Blood; Margaret R Grove; James N Weinstein
Journal:  Ann Intern Med       Date:  2008-12-16       Impact factor: 25.391

10.  Patients' expectations about effects of chemotherapy for advanced cancer.

Authors:  Jane C Weeks; Paul J Catalano; Angel Cronin; Matthew D Finkelman; Jennifer W Mack; Nancy L Keating; Deborah Schrag
Journal:  N Engl J Med       Date:  2012-10-25       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.